Literature DB >> 35538665

Simulations of cross-amyloid aggregation of amyloid-β and islet amyloid polypeptide fragments.

Grant E Kawecki1, Kelsie M King1, Nicholas A Cramer1, David R Bevan2, Anne M Brown3.   

Abstract

Amyloid-β (Aβ) and islet amyloid polypeptide (IAPP) are small peptides, classified as amyloids, that have the potential to self-assemble and form cytotoxic species, such as small soluble oligomers and large insoluble fibrils. The formation of Aβ aggregates facilitates the progression of Alzheimer's disease (AD), while IAPP aggregates induce pancreatic β-cell apoptosis, leading to exacerbation of type 2 diabetes (T2D). Cross-amyloid interactions between Aβ and IAPP have been described both in vivo and in vitro, implying the role of Aβ or IAPP as modulators of cytotoxic self-aggregation of each species, and suggesting that Aβ-IAPP interactions are a potential molecular link between AD and T2D. Using molecular dynamics (MD) simulations, "hotspot" regions of the two peptides were studied to understand the formation of hexamers in a heterogeneous and homogeneous peptide-containing environment. Systems of only Aβ(16-22) peptides formed antiparallel, β-barrel-like structures, while systems of only IAPP(20-29) peptides formed stacked, parallel β-sheets and had relatively unstable aggregation structures after 2 μs of simulation time. Systems containing both Aβ and IAPP (1:1 ratio) hexamers showed antiparallel, β-barrel-like structures, with an interdigitated arrangement of Aβ(16-22) and IAPP(20-29). These β-barrel structures have features of cytotoxic amyloid species identified in previous literature. Ultimately, this work seeks to provide atomistic insight into both the mechanism behind cross-amyloid interactions and structural morphologies of these toxic amyloid species.
Copyright © 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35538665      PMCID: PMC9247468          DOI: 10.1016/j.bpj.2022.05.007

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   3.699


  82 in total

1.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

2.  Comparing atomistic molecular mechanics force fields for a difficult target: a case study on the Alzheimer's amyloid β-peptide.

Authors:  Stacey R Gerben; Justin A Lemkul; Anne M Brown; David R Bevan
Journal:  J Biomol Struct Dyn       Date:  2013-09-13

3.  Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process.

Authors:  Hyunbum Jang; Jie Zheng; Ruth Nussinov
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

4.  Exploring the interplay between fibrillization and amorphous aggregation channels on the energy landscapes of tau repeat isoforms.

Authors:  Xun Chen; Mingchen Chen; Nicholas P Schafer; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

5.  Structural differences between amyloid beta oligomers.

Authors:  Leonid Breydo; Dmitry Kurouski; Suhail Rasool; Saskia Milton; Jessica W Wu; Vladimir N Uversky; Igor K Lednev; Charles G Glabe
Journal:  Biochem Biophys Res Commun       Date:  2016-06-27       Impact factor: 3.575

6.  Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures.

Authors:  Yun-An Lim; Lars M Ittner; Yun Li Lim; Jürgen Götz
Journal:  FEBS Lett       Date:  2008-05-16       Impact factor: 4.124

7.  Familial Alzheimer's disease mutations differentially alter amyloid β-protein oligomerization.

Authors:  Megan Murray Gessel; Summer Bernstein; Martin Kemper; David B Teplow; Michael T Bowers
Journal:  ACS Chem Neurosci       Date:  2012-06-26       Impact factor: 4.418

8.  β-barrel Oligomers as Common Intermediates of Peptides Self-Assembling into Cross-β Aggregates.

Authors:  Yunxiang Sun; Xinwei Ge; Yanting Xing; Bo Wang; Feng Ding
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

Review 9.  Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway.

Authors:  Sami Gabbouj; Simo Ryhänen; Mikael Marttinen; Rebekka Wittrahm; Mari Takalo; Susanna Kemppainen; Henna Martiskainen; Heikki Tanila; Annakaisa Haapasalo; Mikko Hiltunen; Teemu Natunen
Journal:  Front Neurosci       Date:  2019-06-18       Impact factor: 4.677

10.  Pancreatic β-Cell Membrane Fluidity and Toxicity Induced by Human Islet Amyloid Polypeptide Species.

Authors:  Emily H Pilkington; Esteban N Gurzov; Aleksandr Kakinen; Sara A Litwak; William J Stanley; Thomas P Davis; Pu Chun Ke
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

View more
  1 in total

1.  Differential Epigenetic Status and Responses to Stressors between Retinal Cybrids Cells with African versus European Mitochondrial DNA: Insights into Disease Susceptibilities.

Authors:  Shari R Atilano; Sina Abedi; Narcisa V Ianopol; Mithalesh K Singh; J Lucas Norman; Deepika Malik; Payam Falatoonzadeh; Marilyn Chwa; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Cells       Date:  2022-08-26       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.